Big pharma in legal battles for monopoly prices in India

Lofgren, Hans 2012, Big pharma in legal battles for monopoly prices in India, The conversation.


Title Big pharma in legal battles for monopoly prices in India
Author(s) Lofgren, Hans
Source title The conversation
Publisher The Conversation Media Trust
Place of publication Melbourne, Vic.
Publication date 2012-06-05
Section Health
Keyword(s) pharmaceutical policy
India
access to medicines
Summary Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s future as a major global supplier of low-cost essential medicines.
Language eng
Field of Research 160699 Political Science not elsewhere classified
111799 Public Health and Health Services not elsewhere classified
Socio Economic Objective 929999 Health not elsewhere classified
HERDC Research category M Media article
Persistent URL http://hdl.handle.net/10536/DRO/DU:30049909

Document type: Media Article
Collection: School of Humanities and Social Sciences
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Access Statistics: 32 Abstract Views  -  Detailed Statistics
Created: Tue, 18 Dec 2012, 10:43:33 EST by Hans Lofgren

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.